Viatris seeks patent ruling for proposed Wegovy generic
Reuters reports that Viatris sued Novo Nordisk in Delaware federal court, seeking a ruling that its proposed generic would not violate Novo's patent rights.
TLDR
Generic drugmaker Viatris has sued Novo Nordisk over its proposed generic version of Wegovy, Novo's GLP-1 drug, Reuters reports. Viatris is asking a Delaware federal court to rule that the proposed generic would not infringe Novo's patents.
Viatris seeks patent ruling for proposed Wegovy generic
Reuters reports that Viatris sued Novo Nordisk in Delaware federal court, seeking a ruling that its proposed generic would not violate Novo's patent rights.
TLDR
Generic drugmaker Viatris has sued Novo Nordisk over its proposed generic version of Wegovy, Novo's GLP-1 drug, Reuters reports. Viatris is asking a Delaware federal court to rule that the proposed generic would not infringe Novo's patents.